Why it Might Be Wise to Steer Clear of Bank Stocks and Other Lending Companies

Why shareholders of First National Financial Corp. (TSX:FN) and other financial institutions might want to consider selling their shares.

| More on:

As interest rates continue to rise, borrowers are faced with rising costs, which could increase the risk of default. Although interest rates are still very low, many homeowners that locked in mortgages before the rate hikes occurred could see their costs rise when it comes time to renew.

Other consumers that are on variable rates have already seen their costs increase, although buyers on variable rates are subject to more difficult stress tests, making that segment less of a risk for financial institutions.

On Monday, MNP Ltd. released a survey which found that some Canadians claim to have already been impacted by the rate hikes, and 42% of those surveyed expressed concerns about having to go further in debt just to cover basic expenses.

The president of MNP, Grant Bazian, stated in a new release, “It’s clear that people are nowhere near prepared for a higher rate environment.”

What this means for lenders

With many Canadians already stretching their incomes to meet day-to-day needs, consumers with heavy debt loads could pose a significant default risk to banks and other lending companies. First National Financial Corp. (TSX:FN) is a non-bank lender with both corporate and residential customers and is one stock that could be adversely impacted from rising rates.

Commercial borrowers present a significant risk as well, and companies like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) that carry lots of debt could see borrowing costs put further pressure on their financials. Valeant is also close to breaching its debt covenants, and further rate increases could put the company’s ability to meet those obligations in jeopardy.

Tighter mortgage rules will make financial stocks less appealing

Not only will lenders face a higher risk of default from borrowers, but the pool for new loans and mortgages will also be lower. Rising interest rates coupled with harsher stress tests for residential mortgages will likely result in banks and other lenders issuing fewer mortgages to consumers.

Although bank stocks have seen strong growth over the years and in recent quarters, that tide may be turning. In its most recent quarter, Royal Bank of Canada (TSX:RY)(NYSE:RY) saw its revenue from loans and leases rise 4% from the previous year, while Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM) saw that segment grow by 12%.

In the trailing 12 months, over 80% of CIBC’s total interest income has come from loans and leases, while it has made up 70% of Royal Bank’s total. Banks certainly have a lot to lose if mortgages and loans start to decline, which, at this point, seems to be an inevitability.

Why investors should avoid financial stocks today

Although banks are generally safe investments and, over the long term, are able to see strong and stable growth, many are at or near all-time highs. A financial crisis could send the stocks for a big correction, and it may be a good time to sell any gains from financial investments before that time comes.

Not only are we facing a time when interest rates are rising, but consumer debt levels are going in the same direction as well. Oil and gas companies in Alberta are still fragile, and we could see even more corporate bankruptcies come as a result of more rate hikes.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Bank Stocks

Man data analyze
Bank Stocks

Is TD Bank Stock a Buy, Sell, or Hold for 2025?

TD stock has underperformed its large Canadian peers this year. Will 2025 be different?

Read more »

dividends can compound over time
Bank Stocks

Is TD Bank Stock a Buy for Its 5.2% Dividend Yield?

TD Bank stock offers a rare 5.2% dividend yield—can it rebound from challenges and reward contrarian investors? Here's what to…

Read more »

analyze data
Bank Stocks

Is BMO Stock a Buy for its 4.7% Dividend Yield?

Bank of Montreal is up 20% since late August. Are more gains on the way?

Read more »

calculate and analyze stock
Bank Stocks

4% Dividend Yield? I Keep Buying This Dividend Stock in Bulk!

If you find the perfect dividend stock, you never have to worry about investing again. And that's what you get…

Read more »

Investor reading the newspaper
Bank Stocks

Is Canadian Imperial Bank of Commerce Stock a Good Buy?

Let's dive into whether Canadian Imperial Bank of Commerce (TSX:CM) is a top buy, sell, or hold right now.

Read more »

Man data analyze
Bank Stocks

Where Will BNS Stock Be in 3 Years?

Bank of Nova Scotia is primed for growth with a bold U.S. expansion, steady dividends, and a value focus that…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Stocks for Beginners

TFSA 101: Earn $1,596.60 per Year Tax-Free!

Investors don't have to buy some risky stock if they want tax-free high income. Instead, buy this top stock instead.

Read more »

data analyze research
Bank Stocks

TD Bank: Buy, Hold, or Sell Now?

TD is underperforming its large Canadian peers this year. Is a rebound on the way?

Read more »